Gansu Duyiwei Pharmaceutical

Gansu Duyiwei Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern pharmaceuticals. The company is best known for its flagship Duyiwei series, which utilizes extracts from the alpine plant Lamiophlomis rotata to provide analgesic and hemostatic effects. Its product portfolio includes various formulations such as capsules, granules, and soft gels, primarily targeting pain management and surgical recovery. Operating as a key subsidiary of Hengkang Medical Group, the company maintains high-standard GMP-certified production lines in Gansu, China. Gansu Duyiwei Pharmaceutical continues to bridge the gap between traditional herbal knowledge and modern clinical requirements through ongoing product optimization and quality control.